Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children

NCT06288334 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT06288334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06288334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
Lead sponsor
Peking University Third Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
August 6, 2020
Completion date
May 31, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic disease, children